Vector Bioscience is a spin-out company from the University of Cambridge.
About Vector's TECHNOLOGY
Facilitating drug delivery with
lower toxicity, target delivery and an improved shelf-life of RNA treatments.
Vector's platform technology tailors nanomaterials for drug delivery applications.
These nanomaterials are MOFs, Metal Organic Frameworks and they offer multiple benefits. MOFs are nanoscale sponges that can adsorb macromolecules and small molecules. Using computational methods, we pair the best MOF with the therapy needed for treatment.
MOFs can store 10x more molecules than other encapsulation methods and are designed and tailored for effective and targeted delivery to specific biological sites.
More on the science, here.